Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Versus Intravenous N-Acetylcysteine in Bronchiectasis
NCT07293884Completed
- Sponsor
- Assiut University
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of acetylcysteine inhalation solution in bronchiectasis (2 arms), sponsored by Assiut University. Primary endpoint: Change in Expectoration-Difficulty Score at Day 3. Started Jan 2026; status: completed.
02
Drugs
acetylcysteine inhalation solution
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07293884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07293884.